デフォルト表紙
市場調査レポート
商品コード
1608860

非識別化健康データ市場:データタイプ別、用途別、エンドユーザー別、地域別

De-identified Health Data Market, By Type of Data, By Application, By End User, By Geography


出版日
ページ情報
英文 135 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
非識別化健康データ市場:データタイプ別、用途別、エンドユーザー別、地域別
出版日: 2024年11月18日
発行: Coherent Market Insights
ページ情報: 英文 135 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

非識別化健康データ市場は、2024年には75億1,000万米ドルと推定され、2024年から2031年にかけてCAGR9.1%を示し、2031年には138億米ドルに達すると予測されます。

レポート範囲 レポート詳細
基準年 2023年 2024年の市場規模 75億1,000万米ドル
実績データ 2019年~2023年 予測期間 2024年から2031年
予測期間2024年から2031年 CAGR: 9.10% 2031年の金額予測 138億米ドル
図.非識別化健康データ市場シェア(%)、地域別、2024年
De-identified Health Data Market-IMG1

非識別化医療データ市場の成長は、創薬や精密医療のための研究開発活動の増加によってもたらされます。非識別化は、健康データセットから氏名、生年月日、社会保障番号などの識別子を除去することで、患者のプライバシーと機密性を確保します。これにより、研究者やライフサイエンス企業は、倫理を損なうことなく、新規治療法の開発や疫学研究のために大量の健康データを活用することができます。健康記録のデジタル化が世界中で加速するにつれて、二次利用可能な非識別化データの量は増加します。

市場力学

価値観に基づく治療、治療の個別化、デジタルヘルス新興企業の成長への注目の高まりは、非識別化医療データの需要を世界的に押し上げる可能性があります。しかし、データの標準化の欠如や知的財産権をめぐる曖昧さが市場の可能性を阻害する可能性があります。高度なアナリティクス機能の開発は、企業がプールされたデータ資産からより深い洞察を引き出す機会を提供します。政府によるオープンデータ共有イニシアチブの拡大は、こうしたデータセットへのアクセスを拡大する可能性があります。米国政府は、Data.govやHealthData.govのようなイニシアチブを立ち上げ、公衆衛生研究の透明性とイノベーションを促進するために、幅広い健康関連データセットへのオープンアクセスを提供しています。

本調査の主な特徴

本レポートでは、世界の非識別化健康データ市場を詳細に分析し、2023年を基準年とした予測期間(2024年~2031年)の市場規模(10億米ドル)および複合年間成長率(CAGR%)を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業のハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の非識別化健康データ市場の主要企業をプロファイルしています。

本調査の対象となる主要企業には、IQVIA、オラクル(Cerner Corporation)、Merative(Truven Health Analytics)、Optum, Inc.、BioTelemetry, Inc.、Flatiron Health、Veradigm LLC、Medidata Solutions、Evidation Health, Inc.、Komodo Health, Inc.、Sundown Solutions, LLC、Clarify Health Solutions、Akrivia Health、Satori Cyber Ltd.、Tempus、nference、Ciox Health、HealthVerity、Zebra Medical Vision、Huma Therapeuticsなどがあります。

このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界の非識別化健康データ市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。

利害関係者は、世界の非識別化医療データ市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 非識別化健康データ市場、データタイプ別、2019年-2031年

  • 臨床データ
  • ゲノムデータ
  • 患者の人口統計
  • 処方データ
  • クレームデータ
  • 行動データ
  • ウェアラブルとセンサーデータ
  • 調査と患者報告データ
  • 画像データ
  • 検査データ
  • 健康の社会的決定要因(SDOH)データ
  • その他

第5章 非識別化健康データ市場、用途別、2019年-2031年

  • 臨床調査と治験
  • 公衆衛生
  • 精密医療
  • 医療経済とアウトカム調査(HEOR)
  • 人口健康管理
  • 医薬品の発見と開発
  • ヘルスケアの質の向上
  • 保険引受とリスク評価
  • その他

第6章 非識別化健康データ市場、エンドユーザー別、2019年-2031年

  • 製薬会社
  • バイオテクノロジー企業
  • ヘルスケア提供者
  • 保険会社/ヘルスケア支払者
  • 研究機関
  • 政府機関
  • その他

第7章 非識別化健康データ市場、地域別、2019年-2031年

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第8章 競合情勢

  • IQVIA
  • Oracle(Cerner Corporation)
  • Merative(Truven Health Analytics)
  • Optum, Inc.
  • BioTelemetry, Inc.
  • Flatiron Health
  • Veradigm LLC
  • Medidata Solutions
  • Evidation Health, Inc.
  • Komodo Health, Inc.
  • Sundown Solutions, LLC
  • Clarify Health Solutions
  • Akrivia Health
  • Satori Cyber Ltd.
  • Tempus
  • nference
  • Ciox Health
  • HealthVerity
  • Zebra Medical Vision
  • Huma Therapeutics

第9章 アナリストの推奨事項

  • 運命の輪
  • アナリストの見解
  • 一貫した機会マップ

第10章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7476

De-identified health data market is estimated to be valued at USD 7.51 Bn in 2024 and is expected to reach USD 13.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 7.51 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 9.10% 2031 Value Projection: 13.80 Bn
Figure. De-identified Health Data Market Share (%), By Region, 2024
De-identified Health Data Market - IMG1

De-identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De-identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de-identified data available for secondary usage.

Market Dynamics

Rising focus on value-based care, personalization of treatment, and growth of digital health startups can boost demand for de-identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health-related datasets to encourage transparency and innovation in public health research.

Key features of the study

This report provides in-depth analysis of the global de-identified health data market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global de-identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global de-identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global de-identified health data market

Market Segmentation

  • Type of Data Insights (Revenue, USD Bn, 2019 - 2031)
    • Clinical Data
    • Genomic Data
    • Patient Demographics
    • Prescription Data
    • Claims Data
    • Behavioral Data
    • Wearable and Sensor Data
    • Survey and Patient-Reported Data
    • Imaging Data
    • Laboratory Data
    • Social Determinants of Health (SDOH) Data
    • Others
  • Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Clinical Research and Trials
    • Public Health
    • Precision Medicine
    • Health Economics and Outcomes Research (HEOR)
    • Population Health Management
    • Drug Discovery and Development
    • Healthcare Quality Improvement
    • Insurance Underwriting and Risk Assessment
    • Others
  • End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Pharmaceutical Companies
    • Biotechnology Firms
    • Healthcare Providers
    • Insurance Companies/Healthcare Payers
    • Research Institutions
    • Government Agencies
    • Others
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • IQVIA
    • Oracle (Cerner Corporation)
    • Merative (Truven Health Analytics)
    • Optum, Inc.
    • BioTelemetry, Inc.
    • Flatiron Health
    • Veradigm LLC
    • Medidata Solutions
    • Evidation Health, Inc.
    • Komodo Health, Inc.
    • Sundown Solutions, LLC
    • Clarify Health Solutions
    • Akrivia Health
    • Satori Cyber Ltd.
    • Tempus
    • nference
    • Ciox Health
    • HealthVerity
    • Zebra Medical Vision
    • Huma Therapeutics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • De-identified Health Data Market, By Type of Data
    • De-identified Health Data Market, By Application
    • De-identified Health Data Market, By End User
    • De-identified Health Data Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. De-identified Health Data Market, By Type of Data, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Clinical Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Genomic Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Patient Demographics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Prescription Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Claims Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Behavioral Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Wearable and Sensor Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Survey and Patient-Reported Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Imaging Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Laboratory Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Social Determinants of Health (SDOH) Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. De-identified Health Data Market, By Application, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Clinical Research and Trials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Public Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Precision Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Health Economics and Outcomes Research (HEOR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Population Health Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Healthcare Quality Improvement
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Insurance Underwriting and Risk Assessment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. De-identified Health Data Market, By End User, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biotechnology Firms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Healthcare Providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Insurance Companies/Healthcare Payers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Government Agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. De-identified Health Data Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive landscape

  • IQVIA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oracle (Cerner Corporation)
  • Merative (Truven Health Analytics)
  • Optum, Inc.
  • BioTelemetry, Inc.
  • Flatiron Health
  • Veradigm LLC
  • Medidata Solutions
  • Evidation Health, Inc.
  • Komodo Health, Inc.
  • Sundown Solutions, LLC
  • Clarify Health Solutions
  • Akrivia Health
  • Satori Cyber Ltd.
  • Tempus
  • nference
  • Ciox Health
  • HealthVerity
  • Zebra Medical Vision
  • Huma Therapeutics

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us